ArticleBMC complementary medicine and therapies2026
LC-MS/MS-based phytochemical profiling and preliminary in vitro anticancer-related bioactivity of Euphorbia petrophila ethanol extract.
Article in BMC complementary medicine and therapies, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEuphorbia species contain diverse secondary metabolites with reported biological activities, but Euphorbia petrophila remains pharmacologically underexplored. This study aimed to characterize the phytochemical profile of E. petrophila ethanol extract and evaluate its preliminary in vitro anticancer-related activity in lung and breast cancer cell models.
methodsAerial parts of E. petrophila were extracted with ethanol using ultrasonic-assisted extraction. The extract was profiled by LC-MS/MS. Cytotoxicity was assessed by MTT assay in A549 and MDA-MB-231 cancer cells and in BEAS-2B and MCF10A non-tumorigenic epithelial cells. Apoptosis and cell-cycle distribution were analyzed by flow cytometry. Migration and invasion were evaluated using Transwell assays, and selected gene-expression changes were measured by RT-qPCR. Data were analyzed using appropriate analysis of variance and post hoc comparisons.
resultsLC-MS/MS analysis identified phenolic acids and flavonoids, with gallic acid, quinic acid, ellagic acid, and isoquercitrin among the most abundant detected constituents. The extract reduced IC₅₀ value of in all tested cell lines, with the strongest cytotoxic effect observed in A549 cells. It increased apoptotic cell populations and promoted G0/G1 cell-cycle accumulation, particularly in A549 cells. The extract also markedly suppressed migration and invasion in A549 and MDA-MB-231 cells. These functional effects were accompanied by changes in TP53 and CDKN1A mRNA expression.
conclusionsE. petrophila ethanol extract shows preliminary antiproliferative, pro-apoptotic, anti-migratory, and anti-invasive activity in selected cancer cell models. However, because the findings are based on crude extract testing and transcript-level analyses, the results should be interpreted as preliminary and correlative. Further work should include extract standardization, LC-MS/MS method validation, broader normal-cell toxicity profiling, active-compound isolation, protein-level mechanistic assays, and in vivo safety and efficacy studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.